Stuart L. Schreiber,Raymond T. Chung,Lee F. Peng,Sun Suk Kim,Sirinya Matchacheep,John A. Porco, JR.,Aaron B. Beeler
申请号：
US12594701
公开号：
US20120094939A1
申请日:
2008.04.04
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention is directed to compounds of formulae (I) and (II) and pharmaceutically acceptable forms thereof pharmaceutical compositions thereof and methods of treating a viral infection, such as a hepatitis C virus (HCV) infection, by administering to a subject diagnosed with or being susceptible to the viral infection a compound of formulae (I) and (II), a pharmaceutically acceptable form thereof, or a pharmaceutical composition thereof. The present invention is also directed to high-throughput methods of identifying compounds able to modulate hepatitis C virus (HCV) replication activity.
